Rezo Therapeutics Funding: $78M Raised, Series A (2022)
Rezo Therapeutics is based in San Francisco, California. It has raised $78M in total funding. Latest round: Series A.
Rezo Therapeutics funding overview
Rezo Therapeutics is based in San Francisco, California. Rezo Therapeutics has raised $78M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2022. The round record for Rezo Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include SR One, a16z Bio + Health, Norwest Venture Partners, SV Angel, Liquid 2 Ventures, Hawktail. 6 distinct backers are named across the disclosed rounds.
Rezo Therapeutics at a glance
Total raised
$78M
Latest round
Series A
Latest round date
November 2022
Headquarters
San Francisco, California
Notable investors
SR One, a16z Bio + Health, Norwest Venture Partners, SV Angel, Liquid 2 Ventures, Hawktail
Frequently asked about Rezo Therapeutics funding
How much has Rezo Therapeutics raised?
Rezo Therapeutics has raised $78M in total disclosed funding across the rounds on record.
Who has invested in Rezo Therapeutics?
SR One, a16z Bio + Health, Norwest Venture Partners, SV Angel, Liquid 2 Ventures, Hawktail are named among the investors backing Rezo Therapeutics.
What was the latest Rezo Therapeutics funding round?
The most recent disclosed round is a Series A, announced in November 2022.
Where is Rezo Therapeutics based?
Rezo Therapeutics is based in San Francisco, California.
When did Rezo Therapeutics last raise?
The last disclosed Rezo Therapeutics round closed in November 2022 at Series A.
Every Rezo Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Francisco at a similar stage.
